BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 18032459)

  • 1. The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial.
    Henriksson M; Epstein DM; Palmer SJ; Sculpher MJ; Clayton TC; Pocock SJ; Henderson RA; Buxton MJ; Fox KA
    Heart; 2008 Jun; 94(6):717-23. PubMed ID: 18032459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of an early intervention versus a conservative strategy in acute coronary syndrome.
    Epstein DM; Sculpher MJ; Clayton TC; Henderson RA; Pocock SJ; Buxton MJ; Fox KA
    Int J Cardiol; 2008 Jul; 127(2):240-6. PubMed ID: 17707103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
    Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S
    Circulation; 2007 May; 115(18):2398-409. PubMed ID: 17452609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is an invasive interventional strategy of value in non-ST-elevation acute coronary syndromes?
    Weintraub WS
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):754-5. PubMed ID: 18838964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK.
    Karnon J; Bakhai A; Brennan A; Pandor A; Flather M; Warren E; Gray D; Akehurst R
    Int J Cardiol; 2006 May; 109(3):307-16. PubMed ID: 16026869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data.
    Fox KA; Clayton TC; Damman P; Pocock SJ; de Winter RJ; Tijssen JG; Lagerqvist B; Wallentin L;
    J Am Coll Cardiol; 2010 Jun; 55(22):2435-45. PubMed ID: 20359842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
    Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
    Berg J; Lindgren P; Spiesser J; Parry D; Jönsson B
    Clin Ther; 2007 Jun; 29(6):1184-202. PubMed ID: 17692733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysis.
    Kourlaba G; Fragoulakis V; Maniadakis N
    Appl Health Econ Health Policy; 2012 Jul; 10(4):261-71. PubMed ID: 22667992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis.
    McKenna C; Bojke L; Manca A; Adebajo A; Dickson J; Helliwell P; Morton V; Russell I; Torgerson D; Watson J
    Rheumatology (Oxford); 2009 May; 48(5):558-63. PubMed ID: 19258378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of early versus selectively invasive strategy in patients with acute coronary syndromes without ST-segment elevation.
    Dijksman LM; Hirsch A; Windhausen F; Asselman FF; Tijssen JG; Dijkgraaf MG; de Winter RJ;
    Int J Cardiol; 2009 Jan; 131(2):204-11. PubMed ID: 18199496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of anticoagulation strategies in non-ST-elevation acute coronary syndromes.
    Maxwell CB; Holdford DA; Crouch MA; Patel DA
    Ann Pharmacother; 2009 Apr; 43(4):586-95. PubMed ID: 19336655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Falls and health status in elderly women following first eye cataract surgery: an economic evaluation conducted alongside a randomised controlled trial.
    Sach TH; Foss AJ; Gregson RM; Zaman A; Osborn F; Masud T; Harwood RH
    Br J Ophthalmol; 2007 Dec; 91(12):1675-9. PubMed ID: 17585002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention for Endpoint reduction in hypertension (LIFE) study.
    McInnes G; Burke TA; Carides G
    J Hum Hypertens; 2006 Jan; 20(1):51-8. PubMed ID: 16357874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brief pain management program compared with physical therapy for low back pain: results from an economic analysis alongside a randomized clinical trial.
    Whitehurst DG; Lewis M; Yao GL; Bryan S; Raftery JP; Mullis R; Hay EM
    Arthritis Rheum; 2007 Apr; 57(3):466-73. PubMed ID: 17394176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: one-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3).
    Kim J; Henderson RA; Pocock SJ; Clayton T; Sculpher MJ; Fox KA;
    J Am Coll Cardiol; 2005 Jan; 45(2):221-8. PubMed ID: 15653019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial.
    Rivero-Arias O; Campbell H; Gray A; Fairbank J; Frost H; Wilson-MacDonald J
    BMJ; 2005 May; 330(7502):1239. PubMed ID: 15911536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-hospital invasive strategy and outcomes in non-ST elevation acute coronary syndrome management from Thai Acute Coronary Syndrome Registry.
    Phrommintikul A; Kuanprasert S; Limpijankit T; Hengrassamee K
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():74-80. PubMed ID: 18431889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of high-dose atorvastatin compared with regular dose simvastatin.
    Lindgren P; Graff J; Olsson AG; Pedersen TJ; Jönsson B;
    Eur Heart J; 2007 Jun; 28(12):1448-53. PubMed ID: 17371782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.